Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
30.21
-0.40 (-1.32%)
At close: Jul 18, 2025, 4:00 PM
30.21
0.00 (0.00%)
After-hours: Jul 18, 2025, 4:04 PM EDT
Surmodics Market Cap
Surmodics has a market cap or net worth of $431.98 million as of July 18, 2025. Its market cap has decreased by -27.70% in one year.
Market Cap
431.98M
Enterprise Value
439.43M
1-Year Change
-27.70%
Ranking
Category
Stock Price
$30.21
Market Cap Chart
Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $431.98M, an increase of 539.97%. That is a compound annual growth rate of 7.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 17, 2025 | 437.80M | -22.83% |
Dec 31, 2024 | 567.30M | 10.24% |
Dec 29, 2023 | 514.60M | 7.43% |
Dec 30, 2022 | 479.00M | -28.45% |
Dec 31, 2021 | 669.50M | 12.48% |
Dec 31, 2020 | 595.20M | 6.04% |
Dec 31, 2019 | 561.30M | -11.36% |
Dec 31, 2018 | 633.20M | 72.63% |
Dec 29, 2017 | 366.80M | 9.33% |
Dec 30, 2016 | 335.50M | 27.86% |
Dec 31, 2015 | 262.40M | -7.67% |
Dec 31, 2014 | 284.20M | -15.16% |
Dec 31, 2013 | 335.00M | 2.20% |
Dec 31, 2012 | 327.80M | 27.55% |
Dec 30, 2011 | 257.00M | 23.97% |
Dec 31, 2010 | 207.30M | -47.64% |
Dec 31, 2009 | 395.90M | -11.31% |
Dec 31, 2008 | 446.40M | -54.99% |
Dec 31, 2007 | 991.70M | 73.25% |
Dec 29, 2006 | 572.40M | -16.56% |
Dec 30, 2005 | 686.00M | 19.85% |
Dec 31, 2004 | 572.40M | 38.03% |
Dec 31, 2003 | 414.70M | -16.41% |
Dec 31, 2002 | 496.10M | -18.92% |
Dec 31, 2001 | 611.90M | 0.02% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 710.61B |
Johnson & Johnson | 397.12B |
AbbVie | 336.06B |
Novo Nordisk | 299.09B |
UnitedHealth Group | 265.23B |
Novartis AG | 234.87B |
Abbott Laboratories | 228.42B |
AstraZeneca | 217.99B |